Citadel Advisors »

Silence Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $378k 22k 17.37
2022-06-30 $136k 11k 11.89

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Silence Therapeutics

Artal Group
BVF
Vivo Capital
Aquilo Capital Management
Frazier Life Sciences Management
Logos Global Management
M28 Capital Management
Lynx1 Capital Management
Hsbc Holdings
Cantor Fitzgerald, L. P.
UBS Group
Citigroup
Schonfeld Strategic Advisors
William Blair $ Company
Citadel Advisors

View all funds holding Silence Therapeutics